No Data
No Data
Vita Life Sciences Issues H1 Sales Guidance of AU$39 Million to AU$40 Million
Vita Life Sciences (ASX:VLS) issued sales guidance for the half year ending June 30 of AU$39 million to AU$40 million, up from AU$34.7 million a year earlier, according to a Thursday Australian bourse
Investors in Vita Life Sciences (ASX:VLS) Have Seen Stellar Returns of 216% Over the Past Five Years
Is Vita Life Sciences Limited's (ASX:VLS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Those Who Invested in Vita Life Sciences (ASX:VLS) Three Years Ago Are up 111%
Are Robust Financials Driving The Recent Rally In Vita Life Sciences Limited's (ASX:VLS) Stock?
A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)
No Data